Safety and Efficacy of AEB071 in Metastatic Uveal Melanoma Patients
Clinical trial NCT01430416 · COMPLETED
Trial details
- NCT number
- NCT01430416
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-12-20
- Primary completion
- 2019-05-22
- Enrollment
- 153
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.